read the guidlines now JayCS. If they are missing out important information about further testing
Well, further testing's definitely got its full place in the long
guidelines. The sense of the summaries is to cut it down to the core.
Omitting it in the 3 summaries to me means they assume docs know that and just want to get them diagnosing faster.
I don't know why they still have wasted space in the
diagnostic worksheet of all places for outlines of people instead of adding that.
I think and hope they will change it in the next revision, as they know like we do that it is an ongoing process.
I've asked FMA UK about it, as they were involved by having a look over it. But they didn't reply in detail. I'll be bugging
them.
What may have happened is that FMA UK saw it was in the guidelines and didn't concentrate on the sheets?
Reevaluating the
information sheet for clinicians, that like the
guidelines also says "FMS is not a diagnosis of exclusion; it can also coexist with other conditions" in the middle and counter-act that with "Symptoms cannot be explained by any other conditions".
Also "Use ACR (American College of Rheumatology) criteria to aid diagnosis" without saying which ones: 1990, 2010/11 or 2016...
And am I being over-critical if the
patient information sheet seems very vague to me? Or is that the easy reading version, and they know people like us will read the other versions too, which are absolutely well readable I'd think, or is that me again?